Granules India Limited

Form 483 issued June 20, 2025 · Sangareddy, India

Inspection
Jun 16 – Jun 20, 2025
Observations
1
Pages
1
FEI number
3003723146

In short: On June 20, 2025, FDA issued a Form 483 with 1 observation to Granules India Limited in Sangareddy, Telangana (FEI 3003723146) after an inspection that ran Jun 16 – Jun 20, 2025. The investigators were Karen A. Briggs and Karishma G. Gopaul. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×) · 211.22 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Failure to document and investigate a…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Granules India Limited?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Granules India Limited?

Karen A. Briggs and Karishma G. Gopaul are named on this Form 483, for the inspection of Jun 16 – Jun 20, 2025. Each investigator has a profile showing what they cite most.

When was Granules India Limited inspected by FDA?

The inspection ran Jun 16 – Jun 20, 2025, and the Form 483 is dated June 20, 2025.

How do I get the full Form 483 for Granules India Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free